CD274 and hepatocellular carcinoma: High enhancement of nodules in HBP has been reported by Aoki et al [37] to be of value for predicting poor response to anti-PD-1/PD-L1 monotherapy for unresectable HCC, highlighting the potential of Gd-EOB to reflect immunological subclasses.